KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesOther Gross PP&E AdjustmentsPension (IS)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShort-Term Debt repayments
Ratios

Imax (IMAX) EBIAT (2016 - 2025)

Imax (IMAX) has disclosed EBIAT for 16 consecutive years, with -$8.1 million as the latest value for Q4 2025.

  • Quarterly EBIAT fell 253.13% to -$8.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $31.9 million through Dec 2025, up 13.23% year-over-year, with the annual reading at $34.9 million for FY2025, 33.83% up from the prior year.
  • EBIAT hit -$8.1 million in Q4 2025 for Imax, down from $20.7 million in the prior quarter.
  • In the past five years, EBIAT ranged from a high of $20.7 million in Q3 2025 to a low of -$14.8 million in Q1 2021.
  • Historically, EBIAT has averaged $1.8 million across 5 years, with a median of $4.4 million in 2024.
  • Biggest five-year swings in EBIAT: surged 326.14% in 2023 and later plummeted 253.13% in 2025.
  • Year by year, EBIAT stood at $10.1 million in 2021, then plummeted by 45.19% to $5.5 million in 2022, then plummeted by 179.84% to -$4.4 million in 2023, then surged by 220.05% to $5.3 million in 2024, then tumbled by 253.13% to -$8.1 million in 2025.
  • Business Quant data shows EBIAT for IMAX at -$8.1 million in Q4 2025, $20.7 million in Q3 2025, and $11.3 million in Q2 2025.